Kırmızı Göz
Özet
Bu bölüm, bebeklik ve çocukluk çağında sıkça karşılaşılan kırmızı göz şikayetinin nedenlerini, teşhis yöntemlerini ve tedavi süreçlerini kapsamlı bir şekilde ele almaktadır. Konjonktivit, keratit ve üveit gibi yaygın durumların yanı sıra, görme kaybına yol açabilecek ciddi oftalmik acillerin ayırt edilmesine yönelik stratejik bir yaklaşım sunmaktadır. Birinci basamak hekimleri için rehber niteliğinde olan bu metin, hangi durumlarda acil uzman sevkine ihtiyaç duyulduğunu ve güncel tedavi protokollerini detaylandırmaktadır.
This chapter provides a comprehensive overview of the causes, diagnosis, and treatment of red eye in infancy and childhood. It offers a strategic approach to differentiating common conditions like conjunctivitis from sight-threatening ophthalmic emergencies such as keratitis and uveitis. Serving as a guide for primary care physicians, the text details current treatment protocols and critical criteria for urgent referral to an ophthalmologist.
Referanslar
Varu DM, Rhee MK, Akpek EK, et al. Conjunctivitis Preferred Practice Pattern®. Ophthalmology 2019; 126: P94–P169.
Leibowitz HM. The red eye. N Engl J Med 2000; 343: 345–351.
Mochizuki M, Sugita S and Kamoi K. Immunological homeostasis of the eye. Prog Retin Eye Res 2013; 33: 10–27.
Ueta M and Kinoshita S. Ocular surface inflammation is regulated by innate immunity. Prog Retin Eye Res 2012; 31: 551–575
Jhanji V, Chan TC, Li EY, et al. Adenoviral keratoconjunctivitis. Surv Ophthalmol 2015; 60: 435–443
Baudouin C, Liang H, Hamard P, et al. The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways. Ophthalmology 2008; 115: 109–115.
Pisella PJ, Pouliquen P and Baudouin C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. Br J Ophthalmol 2002; 86: 418–423.
Fini ME, Schwartz SG, Gao X, et al. Steroid-induced ocular hypertension/glaucoma: focus on pharmacogenomics and implications for precision medicine. Prog Retin Eye Res 2017; 56: 58–83.
Rowe AM, St Leger AJ, Jeon S, et al. Herpes keratitis. Prog Retin Eye Res 2013; 32: 88–101.
Carnt NP, Hoffman JJ, Verma S, et al. Acanthamoeba keratitis: confirmation of the UK outbreak and a prospective case-control study identifying contributing risk factors. Br J Ophthalmol 2018; 102: 1621–1628.
Karahan E, Taşkıran Çömez A. Kırmızı Göz Hastalığı. Klinik Tıp Aile Hekimliği Dergisi 2016: 8(1): 1-5.
Ingaralingam S, Rauz S, Murray PI, et al. Effectiveness of pharmacological agents for the treatment of non-infectious scleritis: a systematic review protocol. Syst Rev 2020; 9: 54.
Tarabishy AB, Schulte M, Papaliodis GN, et al. Wegener’s granulomatosis: clinical manifestations, differential diagnosis, and management of ocular and systemic disease. Surv Ophthalmol 2010; 55: 429–444.
Yip LW, Thong BY, Lim J, et al. Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series. Allergy 2007; 62: 527–531.
Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II epidemiology report. Ocul Surf 2017; 15: 334–365.
Smith RE, Flowers CW Jr. Chronic blepharitis: a review. CLAO J 1995;21:200–207.
McCulley JP, Shine WE. Changing concepts in the diagnosis and management of blepharitis. Cornea 2000; 19:650–658.
Basic and clinical science course 2013–2014, section 8: external disease and cornea. San Francisco (CA): American Academy of Ophthalmology; 2013–2014.
Rosenberg KD, Feuer WJ, Davis JL. Ocular complications of pediatric uve21. itis. Ophthalmology 2004;111:2299–306.
Khaw PT, Shah P, Elkington AR. Injury to the eye. BMJ 2004; 328:36–38
Dart JK, Radford CF, Minassian D, et al. Risk factors for microbial keratitis with contemporary contact lenses. Ophthalmology 2008;115:1647–54.
